MENU

Novavax (NVAX) Ownership - Who owns Novavax?

Industry: @Biotechnology

Profile

Industry
Biotechnology
Address
700 Quince Orchard Road
Phone
+1 240 268-2000
Employees
1534
Web
https://www.novavax.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.46B
P/E Ratio
N/A
Total Cash
501.26M
Projected Growth
N/A
Total Debt
229.33M
Revenue
656.67M
Risk (Beta)
2.62
Dividend Yield
N/A
Total Cash/Share
3.40
Total Debt/Equity
1.05
Revenue/Share
5.75 USD as % of share price

Fundamentals

NVAX
Capitalization
2.46B
P/E Ratio
N/A
Risk (Beta)
2.62
Dividend Yield
N/A
Total Cash
501M
Total Cash/Share
3.40
Total Debt
229M
Total Debt/Equity
1.05
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
5.75%
Revenue
657M
ROE
N/A
Book Value
-867.08M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-3.05
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.42M
Current Ratio
0.90
Current Revenue Per Employee
47115.96
Dividends Per Share - Security
N/A
EBITDA
-337.06M
Float
N/A
Float - Current
N/A
Gross Income Margin
36.91
Revenue To Assets
-27.53
Shares Held By Institutions
700M
Shares Outstanding - Current
147M
Total Liabilities
2.22B
Total Volume MTD
N/A
Value
-1
Gain YTD
247.292
View a ticker or compare two or three
NVAX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company which engages in development of novel recombinant vaccines

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
700 Quince Orchard Road
Phone
+1 240 268-2000
Employees
1534
Web
https://www.novavax.com